INTERPACE BIOSCIENCES, INC. Quarterly Other Assets, Current in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Interpace Biosciences, Inc. quarterly Other Assets, Current history and growth rate from Q4 2010 to Q3 2024.
  • Interpace Biosciences, Inc. Other Assets, Current for the quarter ending September 30, 2024 was $1.7M, a 8.12% increase year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.7M +$128K +8.12% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $1.94M -$426K -18% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.6M -$575K -26.5% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $1.84M -$453K -19.7% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 $1.58M -$34K -2.11% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $2.37M -$330K -12.2% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $2.17M -$604K -21.8% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $2.29M +$815K +55.1% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $1.61M -$1.53M -48.6% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $2.7M -$573K -17.5% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $2.78M -$198K -6.66% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $1.48M -$1.24M -45.7% Dec 31, 2021 10-K 2023-03-27
Q3 2021 $3.14M -$726K -18.8% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $3.27M -$481K -12.8% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $2.98M -$2M -40.2% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $2.72M -$1.13M -29.3% Dec 31, 2020 10-K 2022-03-31
Q3 2020 $3.86M +$339K +9.63% Sep 30, 2020 10-Q 2021-01-20
Q2 2020 $3.75M +$1.77M +89.7% Jun 30, 2020 10-Q/A 2021-01-19
Q1 2020 $4.98M +$3.09M +164% Mar 31, 2020 10-Q/A 2021-01-19
Q4 2019 $3.85M +$1.68M +77.5% Dec 31, 2019 10-K 2021-04-01
Q3 2019 $3.52M +$1.92M +120% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $1.98M +$503K +34.1% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $1.89M +$796K +72.9% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 $2.17M +$998K +85.2% Dec 31, 2018 10-K/A 2021-01-19
Q3 2018 $1.6M +$336K +26.5% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 $1.47M +$98K +7.12% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $1.09M -$176K -13.9% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 $1.17M -$243K -17.2% Dec 31, 2017 10-K 2019-03-21
Q3 2017 $1.27M -$820K -39.3% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 $1.38M -$1.65M -54.5% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 $1.27M -$1.76M -58.1% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 $1.42M -$1.15M -44.9% Dec 31, 2016 10-K 2018-03-23
Q3 2016 $2.09M -$3.43M -62.1% Sep 30, 2016 10-Q 2016-11-17
Q2 2016 $3.02M -$3.61M -54.4% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 $3.02M -$4.04M -57.2% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 $2.57M -$3.07M -54.5% Dec 31, 2015 10-K 2017-03-31
Q3 2015 $5.51M +$157K +2.93% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 $6.63M -$36K -0.54% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 $7.07M +$67K +0.96% Mar 31, 2015 10-Q 2015-05-12
Q4 2014 $5.64M -$1.44M -20.3% Dec 31, 2014 10-K 2016-03-30
Q3 2014 $5.36M -$781K -12.7% Sep 30, 2014 10-Q 2014-11-05
Q2 2014 $6.67M +$645K +10.7% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 $7M +$382K +5.77% Mar 31, 2014 10-Q/A 2014-08-19
Q4 2013 $7.08M +$1.02M +16.7% Dec 31, 2013 10-K 2015-03-05
Q3 2013 $6.14M +$547K +9.79% Sep 30, 2013 10-Q/A 2014-09-30
Q2 2013 $6.03M +$1.32M +28.1% Jun 30, 2013 10-Q 2013-08-05
Q1 2013 $6.62M +$2.54M +62.5% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 $6.07M +$2.4M +65.3% Dec 31, 2012 10-Q/A 2014-09-30
Q3 2012 $5.59M +$2.05M +58.1% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 $4.7M +$443K +10.4% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 $4.07M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 $3.67M +$296K +8.77% Dec 31, 2011 10-K 2013-03-15
Q3 2011 $3.54M Sep 30, 2011 10-Q 2011-11-10
Q2 2011 $4.26M Jun 30, 2011 10-Q 2011-08-10
Q4 2010 $3.37M Dec 31, 2010 10-K 2012-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.